IRIS
CASTRICONI, ROBERTA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 6.283
Totale 6.283
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 6.283
Totale 6.283
Salva come PNG Salva come JPEG
Città #
Genova 5.089
Rapallo 666
Genoa 504
Bordighera 24
Totale 6.283
Salva come PNG Salva come JPEG
Nome #
PVR(CD155) and Nectin-2 (CD112) as ligands of the human DNAM-1 (CD226) activating receptor: involvement in tumor cell lysis 181
PD-L1 expression in metastatic neuroblastoma as an additional mechanism for limiting immune surveillance 176
NK cells and multiple myeloma-associated endothelial cells: molecular interactions and influence of IL-27 160
Natural Killer Cells and Neuroblastoma: Tumor Recognition, Escape Mechanisms, and Possible Novel Immunotherapeutic Approaches. 144
Both CD133(+) and CD133(-) medulloblastoma cell lines express ligands for triggering NK receptors and are susceptible to NK-mediated cytotoxicity 136
Identification of NKp80, a novel triggering molecule expressed by human NK cells. 135
Human NK cell infusions prolong survival of metastatic human neuroblastoma-bearing NOD/scid mice. 126
Main NK cell receptors and their ligands: regulation by microRNAs 125
Pathogen-induced private conversations between natural killer and dendritic cells 120
Function and specificity of human natural killer cell receptors. 120
Analysis of natural killer cells in TAP2-deficient patients: expression of functional triggering receptors and evidence for the existence of inhibitory receptor(s) that prevent lysis of normal autologous cells 118
Analysis of the molecular mechanism involved in 2B4-mediated NK cell activation: evidence that human 2B4 is physically and functionally associated with the linker for activation of T cells 117
M-CSF induces the expression of a membrane-bound form of IL-18 in a subset of human monocytes differentiating in vitro toward macrophages 114
The interaction of human natural killer cells with either unpolarized or polarized macrophages results in different functional outcomes. 113
Natural killer lymphocytes: "null cells" no more. 113
The leukocyte Ig-like receptor (LIR)-1 for the Cytomegalovirus UL18 protein displays a broad specificity for different HLA class I alleles: analysis of LIR-1+ NK cell clones 112
Natural killer cell-mediated killing of freshly isolated neuroblastoma cells: critical role of DNAX accessory molecule-1-poliovirus receptor interaction 111
Soluble HLA-G dampens CD94/NKG2A expression and function and differentially modulates chemotaxis and cytokine and chemokine secretion in CD56bright and CD56dim NK cells. 111
Human NK cells and NK receptors 111
CIS is a negative regulator of IL-15-mediated signals in NK cells 111
Molecular mechanisms directing migration and retention of natural killer cells in human tissues 111
Comparative analysis of human NK cell activation induced by NKG2D and natural cytotoxicity receptors 110
Involvement of natural cytotoxicity receptors in human natural killer cell-mediated lysis of neuroblastoma and glioblastoma cell lines 107
NK Cells, Tumor Cell Transition, and Tumor Progression in Solid Malignancies: New Hints for NK-Based Immunotherapy? 107
PD-L1 expression in metastatic neuroblastoma as an additional mechanism for limiting immune surveillance 106
Cellular ligands for activating NK receptors 105
Molecular and functional characterization of IRp60, a member of the immunoglobulin superfamily that functions as an inhibitory receptor in human NK cells. 104
Immunotherapy in the Treatment of Human Solid Tumors: Basic and Translational Aspects 102
Small round blue cell tumours: diagnostic and prognostic usefulness of the expression of B7-H3 surface molecule. 101
NKp44, a novel triggering surface molecule specifically expressed by activated natural killer cells, is involved in non-major histocompatibility complex-restricted tumor cell lysis. 100
Shaping of adaptive immunity by innate interactions 100
Neuroblastoma-Derived TGF-beta1 Modulates the Chemokine Receptor Repertoire of Human Resting NK Cells. 98
CD59 is physically and functionally associated with natural cytotoxicity receptors and activates human NK cell-mediated cytotoxicity 98
Expression of the DNAM-1 ligands Nectin-2 (CD112) and poliovirus receptor (CD155) on dendritic cells: relevance for natural killer/dendritic cells interaction 98
Cell-laden hydrogel as a clinical-relevant 3D model for analyzing neuroblastoma growth, immunophenotype, and susceptibility to therapies 98
TLR activation of tumor-associated macrophages from ovarian cancer patients triggers cytolytic activity of NK cells. 98
Novel Immunoregulatory Functions of IL-18, an Accomplice of TGF-β1 97
New perspectives in glioma immunotherapy. 97
Neuroblastoma-derived transforming growth factor (TGF) β1 modulates the chemokine receptor repertoire of human resting Natural Killer Cells. 96
Transforming growth factor beta 1 inhibits expression of NKp30 and NKG2D receptors: consequences on the NK-mediated killing of dendritic cells 95
Overview of the Soluble and Membrane-bound Tumor Factors Limiting NKmediated Immune Surveillance 93
Identification of PVR (CD155) and Nectin-2 (CD112) as cell surface ligands for the human DNAM-1 (CD226) activating molecule 92
Imatinib and nilotinib off-target effects on human NK cells, monocytes, and M2 macrophages 90
The analysis of the natural killer-like activity of human cytolytic T lymphocytes revealed HLA-E as a novel target for TCR alpha/beta-mediated recognition 89
Neuroblastoma Cells Modulate Chemokine Receptor Repertoire of Resting NK Cells 89
Role of NKG2D in tumor cell lysis mediated by human NK cells: cooperation with natural cytotoxicity receptors and capability of recognizing tumors of nonepithelial origin 88
TGF-beta1 downregulates the expression of CX3CR1 by inducing miR-27a-5p in primary human NK cells 85
Cytokine-induced expression of killer inhibitory receptors in human T lymphocytes 83
Updated clinical and biological information from the two-stage phase II study of imatinib mesylate in subjects with relapsed/refractory neuroblastoma 82
The SIICA School of Immunology 2017: a gathering for NGS (next generation scientists) 81
Su.64. Natural Killer Cell-mediated Recognition of Human Brain Tumors 80
Functional characterization of natural killer cells in type I leukocyte adhesion deficiency 76
Selective cross-talk among natural cytotoxicity receptors in human natural killers cells 73
Therapeutic and diagnostic methods and compositions targeting 4IG-B7-H3 and its counterpart NK cell receptor 73
Identification of a novel neuroblastoma-associated molecule that protects from NK-mediated lysis 72
Identification of 4Ig-B7-H3 as a novel neuroblastoma-associated molecule that exerts a protective role from natural killer cell-mediated lysis 69
TGFβ1 inhibits the surface expression of the NKp30 and NKG2D triggering NK receptors: consequences for the NK-mediated killing of dendritic cells 66
Expression and function of KIR and natural cytotoxicity receptors in NK-type lymphoproliferative diseases of granular lymphocytes (LDGL) 64
Natural Killer cells recognize and kill human glioblastoma cells with stem cell-like properties 58
ISTOLOGIA di Monesi 7 51
Soluble HLA-G dampens CD94/NKG2A expression and function and differentially modulates chemotaxis and cytokine /chemokine secretion in CD56(bright) and CD56(dim) NK cells 48
Surface NK receptors and their ligands on tumors cells 47
Elementi di istologia e cenni di embriologia 41
Tumor Microenvironment and Hydrogel-Based 3D Cancer Models for In Vitro Testing Immunotherapies 40
NK Cell Function Regulation by TGF-β-Induced Epigenetic Mechanisms 38
Inhibitory axes impacting on the activity and fate of Innate Lymphoid Cells 38
Multiparametric flow cytometry highlights B7-H3 as a novel diagnostic/therapeutic target in GD2neg/low neuroblastoma variants 36
A multi-organ-on-chip to recapitulate the infiltration and the cytotoxic activity of circulating NK cells in 3D matrix-based tumor model 20
Strategies for Potentiating NK-Mediated Neuroblastoma Surveillance in Autologous or HLA-Haploidentical Hematopoietic Stem Cell Transplants 19
B7-H3 in Pediatric Tumors: Far beyond Neuroblastoma 8
Monocyte and Macrophage in Neuroblastoma: Blocking Their Pro-Tumoral Functions and Strengthening Their Crosstalk with Natural Killer Cells 7
miR-24-3p down-regulates the expression of the apoptotic factors FasL and BIM in human natural killer cells 6
Editorial: Recent 3D Tumor Models for Testing Immune-Mediated Therapies 6
Editorial: TGF-β as a Key Regulator of NK and ILCs Development and Functions 4
Totale 6.494
Salva come PNG Salva come JPEG
Categoria #
all - tutte 18.031
article - articoli 17.361
book - libri 304
conference - conferenze 190
curatela - curatele 0
other - altro 0
patent - brevetti 116
selected - selezionate 0
volume - volumi 60
Totale 36.062
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019280 0 0 0 0 0 0 0 0 0 0 149 131
2019/20201.779 68 51 64 111 167 206 267 128 163 312 185 57
2020/2021580 32 70 65 38 27 84 15 49 44 76 29 51
2021/2022852 34 79 66 113 14 53 43 201 38 70 39 102
2022/2023820 81 72 11 85 126 144 3 60 147 6 69 16
2023/2024386 22 69 15 78 29 52 27 38 33 23 0 0
Totale 6.494